Advertisement

Topics

FDA Awards $403k to Treat Autoimmune-Mediated Condition

05:55 EDT 18 Aug 2017 | PharmPro

Protalex awarded grant from FDA Office of Orphan Products Development to foster clinical development of PRTX-100 for the treatment of immune thrombocytopenia.
Contributed Author: 
Protalex, Inc.

Original Article: FDA Awards $403k to Treat Autoimmune-Mediated Condition

NEXT ARTICLE

More From BioPortfolio on "FDA Awards $403k to Treat Autoimmune-Mediated Condition"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...